Addex Therapeutics Ltd (ADXN) Ownership
ADXN ownership summary
as of October 18, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 1.8M
- Float
- 876K shares available to trade
- Short interest
- 0.12% 1,840 shares short
- Days to cover
- 0.05 short interest up 589.1% vs prior month
- Institutions 0.01%
- Other investors 100.00%
ADXN top institutional holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | UBS Group AG | <0.01% | 47 | $130 | +47 (0.0%) | June 30, 2026 |
| 2 | SBI Securities Co Ltd | <0.01% | 1 | $3 | — | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −301 (−100.0%) | June 30, 2026 |
| 4 | Rhumbline Advisers | 0.00% | — | — | −72 (−100.0%) | June 30, 2026 |
| 5 | GAMMA Investing LLC | 0.00% | — | — | −81 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 5, 1 holders added 47 shares and 3 cut 454.
ADXN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ADXN
Institutional investors own 0.0% of Addex Therapeutics's shares and insiders 0.00%. The largest holder is UBS Group AG with <0.01% of the shares (47), as of June 30, 2026. Among the top 5 institutions, 1 added shares and 3 reduced their stake in the latest filings. Short interest is 0.12% of the float, or 0.05 days of average trading volume. The share count rose 1,305.2% since 2014.
Related: ADXN analyst forecast, ADXN key metrics. See the ADXN stock overview for the latest quote and news.
ADXN ownership FAQ
Who owns the most Addex Therapeutics stock?
The largest shareholders of Addex Therapeutics are UBS Group AG (<0.01%), SBI Securities Co Ltd (<0.01%), Morgan Stanley - Brokerage Accounts (0.00%), Rhumbline Advisers (0.00%), GAMMA Investing LLC (0.00%).
What percentage of Addex Therapeutics is owned by institutions?
Institutions hold 0.0% of Addex Therapeutics's shares outstanding; insiders hold 0.00%.
What is Addex Therapeutics's short interest?
1,840 shares of Addex Therapeutics were sold short, 0.12% of the float; at the average daily volume it would take 0.05 days to cover.
How many shares of Addex Therapeutics are outstanding?
Addex Therapeutics has 1.8M shares outstanding, of which 876K are in the public float.